Ativo
InterveXion Therapeutics
Antibody-drug conjugate developer
Fabricantes
- País
- Czechia
- Fundado
- —
- Cidade sede
- —
- Morada sede
- 1400 Spring Street, Suite 125, Silver Spring, MD 20910, USA
- —
- Telefone
- —
- Website
- https://www.intervexion.com/
Sobre
InterveXion Therapeutics develops novel antibody-drug conjugates for targeted cancer therapy, leveraging proprietary linker technology to improve efficacy and safety.
Vacinas
Nenhum dado disponível
FAQ
Nenhum item FAQ disponível.